AVITA Medical Gains FDA Expanded Labels In 'Better Mousetrap' Burn Treatment
Aldeyra Therapeutics: A New Approach To Ocular Inflammatory Diseases With Impressive Clinical Data
Update On Athersys - Trying To Read Between The Lines
Marketplace Contributors 2021 Top Ideas - Part 2
2021 Roundtable: General Outlook - Biotech And Healthcare Investing
2021 Roundtable: Vaccine News - Biotech, Tech, Growth, And Energy Stock Analysis
Mesoblast Needs A Solution To MSC Scalability Issues - Cynata Therapeutics Has An Answer
ThermoGenesis Holdings: Many Short-Term Catalysts In Low-Float Stock
5 Stem Cell Companies Racing Towards COVID-19 ARDS Therapy
Athersys Sees 4 Million Share Insider Buy From Partner Running COVID-19 ARDS Trial In Japan
Athersys - Now In Play For COVID-19 - FDA Fast Tracked Therapy For ARDS
Avita Medical Enters 2020 With Great Momentum
Biotech In 2020: M&A And Gene Therapy In Focus
The Reincarnation Of ThermoGenesis With A Better Mousetrap For CAR-T Manufacturing
The Stem Cell Triple Play Revisited
The Stem Cell Triple Play: 3 Companies With Great Value Drivers
Avita Medical: A Better Mousetrap With FDA Approval To Treat Patient Burns
Keeping Focused Amidst The Biotech Bear
Athersys: A Lucrative China Stem Cell Licensing Deal Seems Imminent
An Interview With Athersys' CEO
Mesoblast Signs Deal In China For Stem Cell Heart Therapies
Athersys/Healios Warrant Structure Bullish For Athersys Shares
Athersys Gets $56 Million From Healios In Stem Cell Deal
A Deep Drill Down To Walmart's Problem In E-Commerce
Athersys Poised For Lucrative Stem Cell Stroke Partnership This Year
BrainStorm Cell Therapeutics ALS Data Not As Promising As Press Releases Indicate
President Obama Signs 21st Century Cures Act - Implications For The Stem Cell Sector
Marketplace Roundtable: The State Of Biotech
All Systems Go On Athersys Pivotal Stem Cell Stroke Trial In Japan - Exploring The Scientific Evidence
Brainstorm Cell Therapeutics: Caution Ahead Of ALS Phase II Data
Stem Cell Company Athersys Firing On All Cylinders In 2016
Cytori Cell Therapy Shows Promising Results In The Erectile Dysfunction Stem Cell Study